Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes

American Journal of Cardiology

Volumn 96, Issue 9, 2005, Pages 1200-1206

  Rao, Sunil V ^a   O'Grady, Kristi ^a   Pieper, Karen S ^a   Granger, Christopher B ^a   Newby, L Kristin ^a   Van De Werf, Frans ^b   Mahaffey, Kenneth W ^a   Califf, Robert M ^a   Harrington, Robert A ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; CONFIDENCE INTERVALS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; SYNDROME;

EID: 27144475755     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.06.056     Document Type: Article

References (30)

1. C.P. Cannon, W.S. Weintraub, L.A. Demopoulos, R. Vicari, M.J. Frey, N. Lakkis, F.J. Neumann, D.H. Robertson, P.T. DeLucca, P.M. DiBattiste Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
2. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina N Engl J Med 338 1998 1498 1505
3. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes N Engl J Med 335 1996 775 782
4. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes: Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy N Engl J Med 339 1998 436 443
5. The PARAGON B Investigators Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes Circulation 105 2002 316 321
6. M. Moscucci, K.A. Fox, C.P. Cannon, W. Klein, J. Lopez-Sendon, G. Montalescot, K. White, R.J. Goldberg Predictors of major bleeding in acute coronary syndromes the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
7. T.D. Kinnaird, E. Stabile, G.S. Mintz, C.W. Lee, D.A. Canos, N. Gevorkian, E.E. Pinnow, K.M. Kent, A.D. Pichard, L.F. Satler Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
8. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
9. J.J. Ferguson, D.J. Kereiakes, A.A. Adgey, K.A. Fox, W.B. Hillegass Jr, M. Pfisterer, C. Vassanelli Safe use of platelet GP IIb/IIIa inhibitors Am Heart J 135 1998 S77 S89
10. The PARAGON Investigators International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network Circulation 97 1998 2386 2395
11. L.D. Fisher, D.Y. Lin Time-dependent covariates in the Cox proportional-hazards regression model Annu Rev Public Health 20 1999 145 157
12. E. Boersma, K.S. Pieper, E.W. Steyerberg, R.G. Wilcox, W.C. Chang, K.L. Lee, K.M. Akkerhuis, R.A. Harrington, J.W. Deckers, P.W. Armstrong Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators Circulation 101 2000 2557 2567
13. F. Van de Werf, H.V. Barron, P.W. Armstrong, C.B. Granger, S. Berioli, G. Barbash, K. Pehrsson, F.W. Verheugt, J. Meyer, A. Betriu Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents a comparison of TNK-tPA and rt-PA Eur Heart J 22 2001 2253 2261
14. S.D. Berkowitz, C.B. Granger, K.S. Pieper, K.L. Lee, J.M. Gore, M. Simoons, P.W. Armstrong, E.J. Topol, R.M. Califf Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction Circulation 95 1997 2508 2516
15. T. Lenderink, E. Boersma, W. Ruzyllo, P. Widimsky, E.M. Ohman, P.W. Armstrong, L. Wallentin, M.L. Simoons Bleeding events with abciximab in acute coronary syndromes without early revascularization an analysis of GUSTO IV-ACS Am Heart J 147 2004 865 873
16. J.H. Chesebro, G. Knatterud, R. Roberts, J. Borer, L.S. Cohen, J. Dalen, H.T. Dodge, C.K. Francis, D. Hillis, P. Ludbrook Thrombolysis In Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76 1987 142 154
17. S.D. Berkowitz, S. Stinnett, M. Cohen, G.J. Fromell, F. Bigonzi Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction Am J Cardiol 88 2001 1230 1234
18. R.C. Francis, C. Hohne, G. Kaczmarczyk, W. Boemke Effect of angiotensin II and endothelin-1 receptor blockade on the haemodynamic and hormonal changes after acute blood loss and after retransfusion in conscious dogs Acta Physiol Scand 180 2004 319 328
19. P. Ponchon, J.L. Elghozi Contribution of humoral systems to the recovery of blood pressure following severe haemorrhage J Auton Pharmacol 17 1997 319 329
20. R. Ferrari, C. Ceconi, S. Curello, O. Visioli The neuroendocrine and sympathetic nervous system in congestive heart failure Eur Heart J 19 suppl F 1998 F45 F51
21. N.T. Mulvihill, J.B. Foley, R.T. Murphy, R. Curtin, P.A. Crean, M. Walsh Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules Heart 85 2001 623 627
22. T.J. McMahon, R.E. Moon, B.P. Luschinger, M.S. Carraway, A.E. Stone, B.W. Stolp, A.J. Gow, J.R. Pawlowski, P. Watke, D.J. Singel Nitric oxide in the human respiratory cycle Nat Med 8 2002 711 717
23. R. Tabrizchi Cardiovascular effects of noradrenaline in hypovolemic haemorrhage role of inducible nitric oxide synthase Eur J Pharmacol 361 1998 227 234
24. S. Mellander, J. Bjornberg, U. Ekelund, P. Alm Cardiovascular regulation by endogenous nitric oxide is essential for survival after acute haemorrhage Acta Physiol Scand 160 1997 57 65
25. D.C. Shields, A.P. Fitzgerald, P.A. O'Neill, C. Muckian, D. Kenny, B. Moran, C.P. Cannon, C.E. Byrne, D.J. Fitzgerald The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists Pharmacogenomics J 2 2002 182 190
26. I.C. Gilchrist, S.D. Berkowitz, T.D. Thompson, R.M. Califf, C.B. Granger Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global Use of Strategies to Open Occluded Coronary Arteries Am Heart J 144 2002 73 80
27. T.R. Tolleson, J.C. O'Shea, J.A. Bittl, W.B. Hillegass, K.A. Williams, G. Levine, R.A. Harrington, J.E. Tcheng Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention observations from the ESPRIT trial J Am Coll Cardiol 41 2003 386 393
28. D.P. de Bono, R.S. More Prevention and management of bleeding complications after thrombolysis Int J Cardiol 38 1993 1 6
29. C.P. Rusconi, J.D. Roberts, G.A. Pitoc, S.M. Nimjee, R.R. White, G. Quick, E. Scardino, W.P. Fay, B.A. Sullenger Antidote-mediated control of an anticoagulant aptamer in vivo Nat Biotechnol 22 2004 1423 1428
30. P.Y. Lee, K.P. Alexander, B.G. Hammill, S.K. Pasquali, E.D. Peterson Representation of elderly persons and women in published randomized trials of acute coronary syndromes JAMA 286 2001 708 713